These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin. Nabel EG; Barry J; Rocco MB; Mead K; Selwyn AP Am J Cardiol; 1989 Mar; 63(11):663-9. PubMed ID: 2493732 [TBL] [Abstract][Full Text] [Related]
43. Hemodynamic attenuation and the nitrate-free interval: alternative dosing strategies for transdermal nitroglycerin. Flaherty JT Am J Cardiol; 1985 Dec; 56(17):32I-37I. PubMed ID: 3000161 [TBL] [Abstract][Full Text] [Related]
47. Attenuation of nitrate effect during an intermittent treatment regimen and the time course of nitrate tolerance. James MA; Papouchado M; Jones JV Eur Heart J; 1991 Dec; 12(12):1266-72. PubMed ID: 1778190 [TBL] [Abstract][Full Text] [Related]
48. [Role of nitrates in the pharmacologic treatment of heart insufficiency]. Diogo AN Rev Port Cardiol; 1989; 8(7-8):541-6. PubMed ID: 2698717 [TBL] [Abstract][Full Text] [Related]
49. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators. Fox KM; Dargie HJ; Deanfield J; Maseri A Br Heart J; 1991 Aug; 66(2):151-5. PubMed ID: 1909152 [TBL] [Abstract][Full Text] [Related]
51. Nitrate formulations and drug delivery systems--an overview. Fung HL Z Kardiol; 1985; 74 Suppl 4():4-9. PubMed ID: 3938115 [TBL] [Abstract][Full Text] [Related]
52. Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance. Holmes AS; Chirkov YY; Willoughby SR; Poropat S; Pereira J; Horowitz JD Br J Clin Pharmacol; 2005 Oct; 60(4):355-63. PubMed ID: 16187967 [TBL] [Abstract][Full Text] [Related]
53. [The problem of tolerance to nitrates and the means to resolve it in patients with exertional stenocardia]. Metelitsa VI; Martsevich SIu; Kokurina EV; Kozyreva MP; Bochkareva EV Ter Arkh; 1993; 65(9):34-40. PubMed ID: 8303592 [TBL] [Abstract][Full Text] [Related]
54. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness? Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072 [TBL] [Abstract][Full Text] [Related]
55. Placebo effect of nitrate monotherapy for myocardial ischemia. Hamer AW Am J Cardiol; 1992 Nov; 70(15):1238-42. PubMed ID: 1442572 [TBL] [Abstract][Full Text] [Related]
56. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress. Minamiyama Y; Takemura S; Hai S; Suehiro S; Okada S Free Radic Biol Med; 2006 Mar; 40(5):808-16. PubMed ID: 16520233 [TBL] [Abstract][Full Text] [Related]
57. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088 [TBL] [Abstract][Full Text] [Related]
58. Nitrate therapy: is there an optimal substance and formulation? Fung HL Eur Heart J; 1991 May; 12 Suppl A():9-12. PubMed ID: 1874273 [TBL] [Abstract][Full Text] [Related]
59. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina. Hirai N; Kawano H; Yasue H; Shimomura H; Miyamoto S; Soejima H; Kajiwara I; Sakamoto T; Yoshimura M; Nakamura H; Yodoi J; Ogawa H Circulation; 2003 Sep; 108(12):1446-50. PubMed ID: 12952843 [TBL] [Abstract][Full Text] [Related]
60. Nitrate therapy and nitrate tolerance in patients with coronary artery disease. Münzel T; Gori T Curr Opin Pharmacol; 2013 Apr; 13(2):251-9. PubMed ID: 23352691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]